Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Memantine and Sodium Oligomannate in Moderate to Severe Alzheimer's Disease
NCT05430867Phase 4Unknown
- Sponsor
- First Affiliated Hospital of Xi'an Jiaotong University
- Start
- Jul 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of sodium oligomannate in Alzheimer's disease (AD), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Status: unknown.
02
Drugs
sodium oligomannate
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT05430867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05430867.